Envestnet Asset Management
PPH icon

Envestnet Asset Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Envestnet Asset Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Sell
6,452
-119
-2% -$12.3K ﹤0.01% 3846
2026
Q1 		$683K Buy
6,571
+2,333
+55% +$249K ﹤0.01% 3710
2025
Q4 		$437K Buy
4,238
+714
+20% +$69.5K ﹤0.01% 3787
2025
Q3 		$318K Sell
3,524
-751
-18% -$65.8K ﹤0.01% 4039
2025
Q2 		$376K Sell
4,275
-722
-14% -$62.6K ﹤0.01% 3903
2025
Q1 		$455K Sell
4,997
-781
-14% -$70.3K ﹤0.01% 3685
2024
Q4 		$499K Sell
5,778
-1,724
-23% -$156K ﹤0.01% 3582
2024
Q3 		$713K Buy
7,502
+336
+5% +$31.9K ﹤0.01% 3315
2024
Q2 		$656K Buy
7,166
+1,671
+30% +$149K ﹤0.01% 3299
2024
Q1 		$498K Sell
5,495
-1,378
-20% -$121K ﹤0.01% 3435
2023
Q4 		$559K Buy
6,873
+1,011
+17% +$79.3K ﹤0.01% 3269
2023
Q3 		$468K Buy
5,862
+856
+17% +$69K ﹤0.01% 3297
2023
Q2 		$394K Buy
5,006
+239
+5% +$18.7K ﹤0.01% 3345
2023
Q1 		$370K Sell
4,767
-63
-1% -$4.86K ﹤0.01% 3339
2022
Q4 		$375K Buy
4,830
+791
+20% +$58.3K ﹤0.01% 3274
2022
Q3 		$272K Buy
+4,039
New +$298K ﹤0.01% 3412
2015
Q3 		– Sell
-105,604
Closed -$7.47M – 3064
2015
Q2 		$7.47M Buy
105,604
+29,127
+38% +$2.1M 0.04% 466
2015
Q1 		$5.37M Buy
76,477
+22,097
+41% +$1.5M 0.03% 538
2014
Q4 		$3.5M Sell
54,380
-17,423
-24% -$1.11M 0.04% 280
2014
Q3 		$4.57M Buy
71,803
+47,749
+199% +$2.96M 0.05% 256
2014
Q2 		$1.49M Buy
+24,054
New +$1.43M 0.02% 435

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Envestnet Asset Management's PPH Position: Q2 2026 in Review

Envestnet Asset Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 1.8% in Q2 2026, selling an estimated $12.3K and leaving 6,452 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #3846.

Envestnet Asset Management first reported a position in PPH in Q2 2014 and has held it in 21 quarters since. The position peaked at $7.47M in Q2 2015. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Envestnet Asset Management held 6,452 shares of VanEck Pharmaceutical ETF worth $706K as of Q2 2026.
  • Envestnet Asset Management sold 119 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $12.3K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3846 holding.
  • Envestnet Asset Management first reported a position in VanEck Pharmaceutical ETF in Q2 2014 and has held it in 21 quarters since.
  • Envestnet Asset Management's VanEck Pharmaceutical ETF position peaked at $7.47M in Q2 2015.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.